Molecular landmarks of tumor hypoxia across cancer types.

被引：0

作者：

Bhandari, Vinayak ^{[1
]}

Hoey, Christianne ^{[1
]}

Liu, Lydia ^{[2
]}

Lalonde, Emilie ^{[1
]}

Ray, Jessica ^{[1
]}

Livingstone, Julie ^{[2
]}

Lesurf, Robert ^{[2
]}

Shiah, Yu-Jia ^{[2
]}

Vujcic, Tina ^{[3
]}

Huang, Xiaoyong ^{[3
]}

Espiritu, Shadrielle M. G. ^{[2
]}

Heisler, Lawrence E. ^{[2
]}

Yousif, Fouad ^{[2
]}

Huang, Vincent ^{[2
]}

Yamaguchi, Takafumi N. ^{[2
]}

Yao, Cindy Q. ^{[2
]}

Sabelnykova, Veronica Y. ^{[2
]}

Fraser, Michael ^{[2
]}

Chua, Melvin L. K. ^{[4
]}

van der Kwast, Theodorus ^{[5
]}

Liu, Stanley K. ^{[1
]}

Boutros, Paul C. ^{[6
]}

Bristow, Robert G. ^{[1
]}

机构：

[1] Univ Toronto, Toronto, ON, Canada

[2] Ontario Inst Canc Res, Toronto, ON, Canada

[3] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada

[4] Natl Canc Ctr Singapore, Singapore, Singapore

[5] Univ Hlth Network, Toronto, ON, Canada

[6] Univ Calif Los Angeles, Los Angeles, CA USA

来源：

CLINICAL CANCER RESEARCH | 2021年 / 27卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

IA-018

引用

页数：1

共 50 条

[31] Exploring the potential for sustainable accessibility across settlement types. A Swedish case
Larsson, Anders
Ellder, Erik
Vafeiadis, Evangelos
Curtis, Carey
Steiner, Albert
TRANSPORTATION RESEARCH PART D-TRANSPORT AND ENVIRONMENT, 2022, 107
[32] Generalization of the proportion congruency effect across conflict types. How general is it?
Jestus Funes, Maria
Montoro-membila, Nuria
Torres, Maryem
Lupianez, Juan
CANADIAN JOURNAL OF EXPERIMENTAL PSYCHOLOGY-REVUE CANADIENNE DE PSYCHOLOGIE EXPERIMENTALE, 2010, 64 (04): : 300 - 300
[33] Prevalence of homologous recombination deficiency among all tumor types.
Heeke, Arielle Lutterman
Baker, Tabari
Lynce, Filipa
Pishvaian, Michael J.
Isaacs, Claudine
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[34] Brightness judgments within minimal part-types is easier than across part types.
Vessel, EA
Biederman, I
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S226 - S226
[35] Association of KMT2C mutations with favorable outcomes with immune checkpoint inhibitors across multiple tumor types.
Liu, Chunling
Duan, Qianqian
Zhang, Qin
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[36] A comprehensive literature review and meta-analysis on prognostic value of BRCAm, HRRm and HRD plus across tumor types.
Shao, Changxia
Marley, Andrew
Tang, Huilin
Wan, Jun
Miller, Chelsey
Brown, Madeline
Song, Yiqing
Han, Jiali
Adeboyeje, Gboyega
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[37] Multiomics analysis of tumor mutational burden across cancer types
Li, Lin
Bai, Long
Lin, Huan
Dong, Lin
Zhang, Rumeng
Cheng, Xiao
Liu, Zexian
Ouyang, Yi
Ding, Keshuo
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 5637 - 5646
[38] Comparison of biomarkers among 34,855 GI cancer samples show heterogeneity of tumor types.
Dawood, Shaheenah S.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[39] Evaluation of the prognostic value of the OncoMasTR RNA panel in diverse tumor types.
Moran, Bruce
Lanigan, Fiona
Russell, Niamh
Barron, Stephen
Wang, Chan-Ju
Jirstrom, Karin
Bracken, Adrian P.
Gallagher, William M.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[40] Corticosteroid use and its impact on the efficacy of immunotherapy in multiple tumor types.
Nelson, Blessie Elizabeth
Greiner, Benjamin
Hong, Angelina
Tipton, Shelby
Lee, Marissa
Dixon, Andre
Venkatesan, Rohit
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

← 1 2 3 4 5 →